Marko Kuisma

Digital, AI based patient monitor software to enable continuous monitoring of patients in the hospital and at home

As the leading global authority on the evolution of digital health technology, Digital Therapeutics Alliance (DTA) is a 501(c)(6) non-profit trade association of industry leaders and stakeholders dedicated to the understanding, adoption, and integration of digital therapeutics into healthcare. DTA works to enable expanded access to high quality, evidence-based digital therapeutics for patients, clinicians, and payors to improve clinical and health economic outcomes. As the leading international organization on digital therapeutic thought leadership and education, DTA provides the digital health ecosystem with the necessary tools to define, evaluate, and utilize DTx products. For more information, please visit: www.dtxalliance.org.

Vaalia is reimagining medication management for cancer and specialty care. We combine human coaching with causal AI to help patients manage their medications, stay on therapy, and achieve better outcomes. Our platform learns from real patient interactions and integrates with clinics to deliver personalized, evidence-driven support where it matters most.

CardioSignal is a health technology company developing groundbreaking solutions for early detection of heart diseases. We are based in Turku, Finland and Palo Alto, CA, United States. The CardioSignal mobile application is a CE-marked class IIa medical device for the detection of atrial fibrillation, available in over 10 countries. The technology we are developing enables a digital cardiac biomarker for other major heart diseases as well. CardioSignal is a brand and a product by Precordior. Originally an academic spinoff, the company’s patented motion sensor technology is built on a decade of research and algorithm development. Our purpose We are supporting healthcare in battling the #1 killer of people in the world. With heart disease numbers only rising, we are facing a health and economic problem described as an epidemic by researchers and physicians around the world. Early identification and treatment of heart disease, such as atrial fibrillation, would help prevent strokes and heart attacks and improve outcomes for individuals and society.

Alex Therapeutics is a digital health company that partners with pharma to support people with treatment and disease-related mental health challenges through clinically validated companion apps. Alex Therapeutics specializes in oncology and rare diseases, which are typically accompanied by complex treatment regimes and emotional distress.

Digital, AI based patient monitor software to enable continuous monitoring of patients in the hospital and at home

As the leading global authority on the evolution of digital health technology, Digital Therapeutics Alliance (DTA) is a 501(c)(6) non-profit trade association of industry leaders and stakeholders dedicated to the understanding, adoption, and integration of digital therapeutics into healthcare. DTA works to enable expanded access to high quality, evidence-based digital therapeutics for patients, clinicians, and payors to improve clinical and health economic outcomes. As the leading international organization on digital therapeutic thought leadership and education, DTA provides the digital health ecosystem with the necessary tools to define, evaluate, and utilize DTx products. For more information, please visit: www.dtxalliance.org.

Vaalia is reimagining medication management for cancer and specialty care. We combine human coaching with causal AI to help patients manage their medications, stay on therapy, and achieve better outcomes. Our platform learns from real patient interactions and integrates with clinics to deliver personalized, evidence-driven support where it matters most.

CardioSignal is a health technology company developing groundbreaking solutions for early detection of heart diseases. We are based in Turku, Finland and Palo Alto, CA, United States. The CardioSignal mobile application is a CE-marked class IIa medical device for the detection of atrial fibrillation, available in over 10 countries. The technology we are developing enables a digital cardiac biomarker for other major heart diseases as well. CardioSignal is a brand and a product by Precordior. Originally an academic spinoff, the company’s patented motion sensor technology is built on a decade of research and algorithm development. Our purpose We are supporting healthcare in battling the #1 killer of people in the world. With heart disease numbers only rising, we are facing a health and economic problem described as an epidemic by researchers and physicians around the world. Early identification and treatment of heart disease, such as atrial fibrillation, would help prevent strokes and heart attacks and improve outcomes for individuals and society.

Alex Therapeutics is a digital health company that partners with pharma to support people with treatment and disease-related mental health challenges through clinically validated companion apps. Alex Therapeutics specializes in oncology and rare diseases, which are typically accompanied by complex treatment regimes and emotional distress.